Abstract
Norcantharidin, the demethylated product of cantharidin has been used for the treatment of hepatoma, carcinomas of esophagus and gastric cardia, leukopenia and hepatitis. Since the enzyme xanthine oxidase is involved in the diseases mentioned above, and the reactive oxygen species produced by the enzyme induces DNA damage and oxidative damage of tissues, fourteen cantharidin analogues and cantharidimide derivatives were tested for their effects on xanthine oxidase. The results showed that these compounds displayed very weak inhibitory effects on xanthine oxidase. Contrary to expectation disodium cantharidate, Norcantharidin, dehydronorcantharidin, disodium dehydronorcantharidate, N-(2-pyridyl) cantharidimide, N-(3-pyridyl) cantharidimide and N-(4-pyridyl) cantharidimide showed a slight stimulating effect on xanthine oxidase at several concentrations.
| Original language | English |
|---|---|
| Pages (from-to) | 2095-2098 |
| Number of pages | 4 |
| Journal | Anticancer Research |
| Volume | 17 |
| Issue number | 3 C |
| Publication status | Published - 1997 |
Keywords
- Cantharidin and cantharidimide analogues
- Toxic substances
- Xanthine oxidase stimulants
ASJC Scopus subject areas
- Oncology
- Cancer Research
